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The Gram-negative bacterial outer membrane (OM) is a unique bilayer that forms an 32 
efficient permeation barrier to protect the cell from noxious compounds 1,2. The defining 33 
characteristic of the OM is lipid asymmetry, with phospholipids comprising the inner 34 
leaflet and lipopolysaccharide (LPS) the outer leaflet1-3. This asymmetry is maintained 35 
by the Mla pathway, a six-component system that is widespread in Gram-negative 36 
bacteria and is thought to mediate retrograde transport of misplaced phospholipids from 37 
the outer leaflet of the OM to the cytoplasmic membrane4. The OM lipoprotein MlaA 38 
performs the first step in this process via an unknown mechanism that does not require 39 
external energy input. Here we show, using X-ray crystallography, molecular dynamics 40 
simulations and in vitro and in vivo functional assays that MlaA is a monomeric a-helical 41 
OM protein that functions as a phospholipid translocation channel, forming a ~20 Å thick 42 
donut embedded in the inner leaflet of the OM with a central, amphipathic pore. This 43 
architecture prevents access of inner leaflet phospholipids to the pore, but allows outer 44 
leaflet phospholipids to bind to a pronounced ridge surrounding the channel, followed by 45 
diffusion towards the periplasmic space. Enterobacterial MlaA proteins form stable 46 
complexes with OmpF/C5,6, but the porins do not appear to play an active role in 47 
phospholipid transport. MlaA represents a lipid transport protein that selectively 48 
removes outer leaflet phospholipids to help maintain the essential barrier function of the 49 
bacterial OM. 50 
 51 
Three systems are known to maintain OM lipid asymmetry; the OM phospholipase A2 PldA7, 52 
the LPS palmitoyl transferase PagP8, and the Mla (maintenance of outer membrane lipid 53 
asymmetry) system. Only the Mla system maintains asymmetry directly via phospholipid 54 
extraction, while PldA and PagP both generate lysophospholipids in the outer leaflet that still 55 
require removal. The Mla system is conserved in Gram-negative bacteria and plant 56 
chloroplasts9,10, consisting of the inner membrane (IM) ABC transporter MlaBDEF, the 57 
periplasmic protein MlaC and the OM lipoprotein MlaA4,6,11. Phenotypes from defects in the 58 
Mla system are mild under laboratory conditions and require small-molecule OM stressors like 59 
SDS/EDTA or antibiotics4-6,11. However, MlaA has been identified as a virulence factor in 60 
various bacteria12-15. In addition, the Mla system was recently shown to regulate outer 61 
membrane vesicle (OMV) formation16. The deleterious effects of Mla knockouts likely result 62 
from phospholipid accumulation in the OM outer leaflet, forming bilayer patches that are 63 
portals for entry of lipophilic small molecules17. So far, structural information on Mla 64 
components is available only for MlaC and MlaD5. MlaC likely accepts a phospholipid from 65 
MlaA and shuttles it to the ABC transporter for ATP-dependent plasma membrane insertion5. 66 
MlaA is the most enigmatic Mla component, particularly since its identity as a periplasmically-67 
exposed lipoprotein appears hard to reconcile with its proposed activity on outer leaflet 68 
phospholipids. 69 
 70 
To elucidate the OM-centered events of the Mla pathway we overexpressed several full-length 71 
bacterial MlaA orthologs in E. coli (Supplementary Fig. 1). MlaA orthologs from Klebsiella 72 
pneumoniae (KpMlaA) and Serratia marcescens (SmMlaA) could be purified in high yields. 73 
Strikingly, both proteins are present in complexes with the trimeric general diffusion porin 74 
OmpF (Supplementary Fig. 2a), confirming earlier observations for the E. coli complex5,6 and 75 
indicating that the MlaA-porin interaction is conserved in Enterobacteria. The X-ray crystal 76 
structures reveal that KpMlaA forms a ~190 kDa, 3:3 complex with OmpF whereas only one 77 
SmMlaA protomer is present per OmpF trimer (Figs. 1a and b and Supplementary Table 1). 78 
The difference in stoichiometry is most likely due to a lower stability of the SmMlaA-OmpF 79 
complex. Since the estimated number of MlaA molecules per cell is only a few percent of that 80 
of OmpF (~105/cell)18, the 3:3 complex observed for KpMlaA is likely due to MlaA 81 
overexpression. The physiologically prevalent complex probably contains one MlaA monomer 82 
per OmpF trimer (1:3). MlaA co-purifies with OmpF and not OmpC probably due to the low-83 
osmolarity growth medium, favoring OmpF expression. Given a recent suggestion that OmpC-84 
MlaA and not OmpF-MlaA is the active species6 we also determined the structure of KpMlaA 85 
with K. pneumoniae OmpC (OmpK36). We find that KpMlaA-OmpK36 is virtually identical 86 
to KpMlaA-OmpF (Supplementary Fig. 2b), calling into question the claim that only OmpC-87 
containing complexes are active6. MlaA is bound in the groove between two OmpF/C 88 
monomers, and interacts with OmpF/C mainly via van der Waals interactions between 89 
hydrophobic residues that would be lipid-exposed in the isolated proteins (Supplementary Fig. 90 
2c). OmpF/C as present in the complexes with MlaA are identical to OmpF/C in isolation (Ca 91 
r.m.s.d 0.3 Å), demonstrating that the MlaA interaction causes only minimal changes in the 92 
porins (Supplementary Fig. 2d). 93 
 94 
KpMlaA and SmMlaA share 83% sequence identity and have very similar structures (Ca 95 
r.m.s.d 0.8 Å; Fig. 1a-c), which as analysed by DALI19 do not resemble that of any other 96 
membrane protein (Supplementary Table 2). The N- and C-terminal ~10-15 residues and the 97 
N-terminal lipid anchor are not visible in the electron density. In the following we will discuss 98 
the KpMlaA structure since it has the lowest R/Rfree values (Supplementary Table 1). 99 
Moreover, partially ordered molecules of LPS are present in the conserved porin LPS binding 100 
site20 in one of the KpMlaA-OmpF structures, providing a physiologically more relevant 101 
picture of the OM outer leaflet (Supplementary Fig. 3). MlaA has a ring-shaped structure and 102 
is predominantly a-helical (Figs. 1b and c) The stable association with OmpF facilitates 103 
analysis of the orientation of MlaA relative to the OM and reveals that, surprisingly, MlaA is 104 
an integral membrane protein (Fig. 1a and Supplementary Fig. 3). Analysis of the electrostatics 105 
shows that the entire MlaA surface, apart from the periplasmic face, is hydrophobic (Figs. 1 e-106 
g). Most of the helices are amphipathic and oriented parallel to the OM except helix 6 (H6), 107 
which is perpendicular to the membrane plane and spans the lipid bilayer (Figs. 1a and c). The 108 
presence of a central channel, ~5 Å wide at its narrowest point, gives MlaA the appearance of 109 
a donut (Fig. 1d). This channel is lined mostly with hydrophilic residues from H2, the long 110 
intra-membrane loop between H4 and H5 ("pore loop"), H5 and the transmembrane H6 (Fig. 111 
1c). The presence of the polar central channel explains why e.g. H6 is not a classical 112 
hydrophobic transmembrane helix. The extracellular end of the channel is formed by a 113 
pronounced, semi-circular ridge comprised of H5, the top of H6 and the loop connecting them 114 
(Figs. 1c and d). The top of the ridge including Trp160 and Trp163 is embedded in the interface 115 
of the outer leaflet (Fig. 1a and Supplementary Fig. 3).  116 
 117 
Atomistic and coarse-grained molecular dynamics (MD) simulations (Supplementary Table 3 118 
and Methods) show that water molecules rapidly fill the central MlaA channel (Figs. 2a and b; 119 
Supplementary Movies 1 and 2), indicating that the channel can accommodate polar molecules. 120 
Asymmetric systems with mixtures of the minimal biologically active endotoxin molecule Re-121 
LPS (KDO2-lipid A) and POPE (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine) in 122 
the outer leaflet and POPE in the inner leaflet yielded limited information due to slow 123 
movement of the LPS molecules, which do not interact with MlaA within 2 µs coarse-grained 124 
simulations (Fig. 2c) and block access of phospholipids to the MlaA pore. Since phospholipids 125 
and LPS do not mix in vitro21, we decided to simulate symmetrical POPE bilayers, mimicking 126 
an OM phospholipid patch17 (Supplementary Fig. 4a and b). These simulations consistently 127 
showed specific interactions of outer leaflet phospholipids with the ridge of MlaA. Following 128 
binding, the PE head group moves ~15 Å down the channel towards the centre of the bilayer, 129 
a movement coupled with tilting of the acyl chains by ~45-90 degrees relative to the membrane 130 
normal (Fig. 2a-c; Supplementary Fig. 5a; Supplementary Movies 1 and 2). In both atomistic 131 
and coarse grained simulations, the head group interacts with several negatively charged 132 
residues in the channel, including Glu146, Asp149 and Asp152 in helix H5 (Supplementary 133 
Figs. 5c and d). Several monovalent cations (Na+, K+) are consistently present at this site and 134 
interact with the acidic residues, possibly to facilitate passage of the phosphate moiety. 135 
Importantly, POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) does not interact with 136 
MlaA (Supplementary Fig. 5b), indicating head group specificity that may reflect the absence 137 
of PC lipids in most enteric bacteria.  138 
 139 
PE phospholipids near the channel constriction in the centre of the bilayer are stably bound on 140 
the timescale of the simulations, raising the question how the phospholipids move further 141 
towards the periplasmic space. The size and polarity of the channel pore in the crystal structure 142 
is sufficient to accommodate the phospholipid head group, but does not allow passage of the 143 
acyl chains. We propose that a relatively minor shift in the position or conformation of the pore 144 
loop tip or H6 (Fig. 1) elongates the pore to accommodate the acyl chains (Supplementary Fig. 145 
6). The pore loop may function as a gate, perhaps opened by MlaC binding, to allow access of 146 
the entire phospholipid molecule. The principal residues restricting passage of the phospholipid 147 
acyl chains are Tyr138 at the pore loop tip, which side chain interacts with that of Trp170 in 148 
H6. Both residues are not well conserved (Fig. 3a) and their substitution by small residues in 149 
some orthologues would alleviate the requirement for conformational changes (Supplementary 150 
Fig. 6). The opened pore would be amphipathic to provide a matching environment for the 151 
substrate (Supplementary Fig. 6d).  152 
 153 
A ConSurf analysis22 of MlaA revealed that the pore-lining and MlaA-OmpF/C interface 154 
residues are generally poorly conserved (Fig. 3a and Supplementary Fig. 1). Most of the 155 
invariant residues are involved in polar helix-helix interactions that likely stabilise the MlaA 156 
fold (e.g. Asp33 and Arg178; numbering of the mature protein, starting with Cys1). Other 157 
invariant residues such as Gln204 are exposed to the periplasmic space and are presumably 158 
important for MlaC interaction. The ConSurf output and the computational data were used for 159 
selection of mutant KpmlaA alleles, which were cloned in a low-copy plasmid and tested for 160 
their ability to complement the growth defect of the DmlaA E. coli strain in the presence of 161 
doxycycline23 (Fig. 3b) and chlorpromazine23 (Supplementary Fig. 7). We did not attempt to 162 
disrupt the MlaA-OmpF/C interaction because too many residues are involved (Supplementary 163 
Fig. 2). We did test the interesting MlaA* variant (lacking residues Asn26-Phe27) that disrupts 164 
phospholipid homeostasis via phospholipid accumulation on the cell surface, leading to cell 165 
death24. 166 
 167 
The E. coli MlaA knockout shows clear growth defects for both doxycycline and 168 
chlorpromazine, small molecules with very different structures (Supplementary Fig. 7f). 169 
Complementation with wild type KpMlaA almost completely restores growth of the knockout, 170 
allowing structure-function studies. All tested variants are fully functional in LB medium in 171 
the absence of antibiotics (Supplementary Fig. 7), and variants are present in the OM as probed 172 
by western blots (Fig. 3 and Supplementary Fig. 7). A double mutant with changes in residues 173 
interacting with the phospholipid head group in MD simulations (D149A, D152A) has no 174 
growth defect. Strikingly, mutation of a third phospholipid-interacting residue (E146) results 175 
in a strong phenotype for the triple mutant (E146A/D149A/D152A) (Supplementary Fig. 7a), 176 
suggesting that Glu146 is particularly important or alternatively, that all head group-interacting 177 
residues need to be removed to compromise function. Single-substitution variants designed to 178 
make the aqueous channel more hydrophobic (E64L, R117L) are indistinguishable from wild-179 
type MlaA, consistent with the fact that these residues are not conserved and suggesting that 180 
the overall properties of the channel are important rather than individual residues. With respect 181 
to invariant residues, most single substitutions have no (P49A, Y195A, R199E) or modest 182 
(N21A, N28A) effects on MlaA function (Fig. 3b), demonstrating that the MlaA fold is robust. 183 
Interesting exceptions are changes in Asp33 in H1 and Arg178 at the bottom of H6, both of 184 
which eliminate MlaA activity and suggest that the salt bridge formed by these two residues is 185 
crucial for function. The most illuminating loss-of-function phenotype is caused by the double 186 
mutant Y138C/W170C. The double cysteine "lock" variant was made to prevent pore 187 
enlargement via disulphide bond formation. The functionality of the double mutant is 188 
recovered in the presence of the reducing agent b-mercaptoethanol (Fig. 3c), providing strong 189 
support for the requirement of conformational shifts of the pore loop and/or H6 for pore 190 
enlargement. The Y138C/W170C mutant is not extracted using Sodium N-lauroyl sarcosine 191 
(sarkosyl) (Supplementary Fig.7e), indicating it is located in the OM25. Moreover, the single 192 
Cys mutants Y138C and W170C have no phenotype (Supplementary Fig. 7a), excluding the 193 
presence of mixed disulphides with e.g. the N-terminal cysteine residue as a cause for the 194 
growth defect of the Y138C/W170C mutant. Finally, changes in residues exposed to the 195 
periplasmic space (Q204A, R205L) have moderate phenotypes, suggesting the interaction with 196 
MlaC may be partially disrupted. Our results also confirm the fundamentally different character 197 
of the KpMlaA* variant24, since its phenotype is clearly more severe than that of the MlaA 198 
knockout (Fig. 3b and Supplementary Fig. 7). To supplement the in vitro data, we also tested 199 
the competitive fitness of wild type KpMlaA and the knockout in vivo, using a Salmonella 200 
typhoid fever mouse model. As shown in Fig. 3d, the knockout has a significant competitive 201 
disadvantage relative to wild type, with a competitive index (CI)26 of 0.21, confirming that 202 
MlaA is important in vivo12-16.  203 
 204 
Our structural and computational data identify MlaA as a monomeric a-helical OM protein, 205 
contrasting with both Wza27 and VirB1028 that form oligomeric water-filled pores in the OM. 206 
The interaction with OmpF reveals that MlaA is embedded in the inner leaflet of the OM which, 207 
together with the donut architecture, is crucial for function. The thickness of the MlaA donut 208 
is ~20 Å, i.e. one leaflet of the OM, and this ensures that inner leaflet phospholipids cannot 209 
gain access to the central channel (Fig. 4a). By contrast, the walls of MlaA do not cover the 210 
OM outer leaflet, allowing outer leaflet phospholipids to diffuse to the center of MlaA to bind 211 
at the ridge (Fig. 2 and 4). Due to their very large size, LPS molecules are not substrates for 212 
MlaA. Phospholipid binding is followed by diffusion of the substrate towards the periplasmic 213 
space, following enlargement of the pore that result from rearrangements of the pore loop, helix 214 
H6, or both (Fig. 4b; transition from state 1 to 2). The postulated conformational change could 215 
be spontaneous or a result of the binding of MlaC to the periplasmic face of MlaA. It is likely 216 
that the phospholipid moves from MlaA into the MlaC binding site5 without being exposed to 217 
the periplasmic space (Fig. 4a). The architecture of MlaA, specifically the physical separation 218 
of the central channel and the inner leaflet, also provides a strong argument against 219 
involvement of the Mla system in anterograde phospholipid transport to the OM5. The striking 220 
phenotype of the Asn26-Phe27D MlaA* variant (Fig. 3b) is most likely due to a disruption in 221 
helix H1 and/or its interaction with the pore loop, resulting in a breach in the MlaA wall (Fig. 222 
4b; state 3). This would "short-circuit" the system and now allow lateral access of inner leaflet 223 
phospholipids to the central channel (Fig. 4b; state 3 arrow), followed by a rapid, reversed flow 224 
to the outer leaflet driven by the steep concentration gradient of phospholipids between both 225 
leaflets.  226 
 227 
The intriguing question why Enterobacterial MlaA proteins are present in stable complexes 228 
with OmpF and OmpC remains. Our crystal structures suggest that all functionality required 229 
for removal of OM phospholipids is contained within MlaA. When expressed without a signal 230 
sequence and lipid anchor, KpMlaAcyto (Methods) is still membrane-associated but does not 231 
co-purify with OmpF (Supplementary Fig. 2a), consistent with MlaA now being localised in 232 
the IM. Interestingly, this MlaA variant severely aggregates in mild detergents in which MlaA-233 
porin complexes are stable (Methods), suggesting MlaA might not be stable on its own in the 234 
lipid bilayer. Alternatively, the porins might function as a scaffold for correct positioning or to 235 
otherwise enable MlaA to carry out its function (Supplementary Fig. 4c).  236 
 237 
Unlike lipid flippases or floppases29-30, MlaA functions in an energy-independent fashion. 238 
While we argue that the MlaA* variant would function as a scramblase29-30 in a regular 239 
phospholipid bilayer, wild type MlaA represents a different class of lipid transport protein 240 
because it removes phospholipids from the OM via bypassing the inner leaflet, i.e. MlaA is a 241 
phospholipid translocation channel. Once returned to the IM via MlaC and MlaBDEF, the 242 
phospholipids likely join the general pool and may be transported back to the OM. The way in 243 
which this occurs is the biggest mystery in bacterial lipid homeostasis1,2, but could perhaps 244 
mechanistically resemble steps in the Mla pathway. 245 
 246 
Methods 247 
Cloning, expression and purification of MlaA proteins. Genomic DNAs from Klebsiella 248 
pneumoniae, Serratia marcescens, Pseudomonas aeruginosa, Escherichia coli, Acinetobacter 249 
baumannii and Neisseria meningitidis were used to amplify KpmlaA, SmmlaA, PamlaA, 250 
EcmlaA, AbmlaA and NmmlaA genes (UniProt: A0A0W8AQT6, A0A0U8E5M0, Q9I043, 251 
A0A1J0HDI0, V5VGD0 and A0A0Y6GKR8 respectively). Amplification products were 252 
cloned under the control of an arabinose inducible promoter via NcoI-XbaI (except for AbmlaA 253 
that was via EcoRI-XbaI) into pBAD2431. Primers were designed to add a C-terminal hexa-254 
Histidine tag during PCR amplification. Expression plasmids were transformed into an E. coli 255 
C43 (DE3) strain32 lacking cytochrome bo3 ubiquinol oxidase (encoded by the cyoABCD 256 
operon) to facilitate OM protein purification due to the intrinsic affinity of the Cyo complex 257 
for metal affinity columns. Cells were grown in low salt LB (LB Broth low salt granulated 258 
(Melford Biolaboratories Ltd), consisting of Tryptone 10 g/l, NaCl 5 g/l and yeast extract 5 g/l. 259 
Protein expression was induced with 0.1 % of arabinose added at an OD600 of 0.6, followed by 260 
further incubation of the cultures at 37°C whilst shaking at 150 rpm during 3-4 hours. After 261 
cell disruption (Constant Systems 0.75 kW operated at 20-23,000 psi), the membrane fraction 262 
was harvested by centrifugation (45 min at 42,000 rpm using a 45 Ti Beckman rotor). The 263 
processing of small-scale, 1 litre cultures demonstrated that of the tested orthologs, only 264 
KpMlaA and SmMlaA were stable and produced in yields high enough to warrant scale-up to 265 
6-8 liters of cells. Typically, membranes from eight litres of cells producing KpMlaA or 266 
SmMlaA were solubilized in 100 ml Tris-buffered saline (TBS) with 0.5% DM (n-Decyl-β-D-267 
Maltopyranoside; Anatrace) and 0.5% DDM (n-Dodecyl-β-D-Maltopyranoside; Anatrace) 268 
during 1 hour at 4°C with stirring. Insoluble particles were removed by centrifugation (30 min 269 
42,000) and the supernatant loaded onto an 8-10 ml nickel column previously equilibrated with 270 
5 column volumes (CV) of wash buffer (TBS containing 10% glycerol, 25mM imidazole and 271 
0.15% DDM) and then washed with 15-20 CV of the same buffer. Finally, proteins were eluted 272 
with 3 CV of wash buffer supplemented with 250 mM imidazole. KpMlaA was buffer 273 
exchanged into 10 mM HEPES pH7.5, 150 mM NaCl, 5% glycerol and 0.4% C8E4 274 
(Tetraethylene Glycol Monooctyl Ether; Anatrace) using an Amicon Ultra-15 Centrifugal 275 
Filter Unit (100,000 kD cut-off). SmMlaA was further purified by size-exclusion 276 
chromatography run (HiLoad 26/600 Superdex 200, GE healthcare) using 10 mM Tis-HCl pH 277 
8, 150 mM NaCl, 10% glycerol and 0.4% C8E4. To assess the purity of the proteins, samples 278 
were run on 4-12% NuPAGE SDS gels (Life Technologies). Both proteins co-purified in stable 279 
complexes with the E. coli trimeric general diffusion porin OmpF (Supplementary Fig. 2a), 280 
confirmed via analysis of gel bands by mass spectrometry (data not shown). KpMlaA-OmpF 281 
and SmMlaA-OmpF complexes were concentrated to at least 10 mg/ml and flash-frozen in 282 
liquid nitrogen.  283 
Purification of KpMlaAcyto. KpmlaA-pBAD24 plasmid was used as a PCR template, and 284 
primers were designed to remove the signal sequence and the anchor cysteine and to introduce 285 
the NcoI and XhoI restriction sites. The PCR product was cloned in pET28b. The expression 286 
plasmid was transformed into an E. coli BL21 (DE3) strain. Cells were grown in low salt LB 287 
(LB Broth low salt granulated (Melford Biolaboratories Ltd), consisting of Tryptone 10 g/l, 288 
NaCl 5 g/l and yeast extract 5 g/l. Protein expression was induced with 1mM of IPTG added 289 
at an OD600 of 0.6, followed by further incubation of the cultures at 37°C whilst shaking at 150 290 
rpm during 3-4 hours. After cell disruption (Constant Systems 0.75 kW operated at 20-23,000 291 
psi), the membrane fraction was harvested by centrifugation (45 min at 42,000 rpm using a 45 292 
Ti Beckman rotor). Membranes from one litre of cells producing KpMlaAcyto were solubilized 293 
in 100 ml Tris-buffered saline (TBS) with 0.5% DM and 0.5% DDM during 1 hour at 4°C with 294 
stirring. Insoluble particles were removed by centrifugation (30 min 42,000) and the 295 
supernatant loaded onto an 8-10 ml nickel column previously equilibrated with 5 column 296 
volumes (CV) of wash buffer (TBS containing 10% glycerol, 25mM imidazole and 0.15% 297 
DDM) and then washed with 15-20 CV of the same buffer containing 30 mM imidazole. 298 
Finally, the protein was eluted with 3 CV of wash buffer supplemented with 250 mM 299 
imidazole. KpMlaAcyto was further purified by size-exclusion chromatography run (HiLoad 300 
26/600 Superdex 200, GE healthcare) using 10 mM Tis-HCl pH 8, 150 mM NaCl, 10% 301 
glycerol and 0.05% DDM. Under these conditions KpMlaAcyto severely aggregated and eluted 302 
in the void volume. Replacing the mild detergent DDM with the harsher detergent n-Dodecyl-303 
N,N-Dimethylamine-N-Oxide (LDAO Anatrace, 1.5% for extraction,  0.2% for the Nickel 304 
column and 0.05% for the size-exclusion) allowed us to purify stable KpMlaAcyto. Under these 305 
conditions, this shorter MlaA version does not form complexes with OmpF (Supplementary 306 
Fig. 2a), probably because it is located in the IM. As a control, during the LDAO purification 307 
the supernatant after the first spin (corresponding to the soluble protein fraction) was loaded 308 
onto a Nickel column but no KpMlaAcyto was present in the elution. 309 
 310 
Purification of KpMlaA-Y138C/W170C 311 
The purification was performed as described above for KpMlaA with one modification; prior 312 
to the protein extraction in 0.5% DM and 0.5% DDM the IM was solubilized twice in 20 mM 313 
HEPES pH 7.5 plus 0.5% sodium N-lauroyl sarcosine25 and the sample was centrifuged each 314 
time for 30 min at 42000 rpm. The pellet was collected and processed as described above via 315 
extraction with DM and DDM. 316 
 317 
Cloning, co-expression and purification of KpMlaA-OmpK36 complex. KpmlaA was 318 
subcloned from the above mentioned pBAD24-derivative into pBAD322c33 via NcoI-XbaI 319 
sites. The gene for the K. pneumoniae ompC ortholog, (coding for OmpK36; UniProt 320 
F2VN85), was cloned into a pBAD24 vector. The E. coli Omp8 strain, an expression host 321 
lacking the major outer membrane proteins including OmpF and OmpC34, was electroporated 322 
with the expression vectors OmpK36 (ChlR) and KpMlaA (pBAD24; ampR), plates and 323 
cultures were supplemented with chloramphenicol (34 µg/ml) and ampicillin (100 µg/ml) to 324 
maintain both plasmids. Expression and purification were carried out as described above for 325 
KpMlaA with one modification; prior to the protein extraction in 0.5% DM and 0.5% DDM 326 
the IM was solubilized once in TBS plus 0.5% sodium N-lauroyl sarcosine25  and the sample 327 
was centrifuged for 30 min at 42000 rpm. The pellet was collected and processed as described 328 
above. 329 
 330 
Crystallisation and structure determination of KpMlaA-OmpF, SmMlaA-OmpF and 331 
KpMlaA-OmpK36 complexes. Sitting drop vapour diffusion crystallization trials were set up 332 
with a Mosquito Crystallization robot (TTP Labtech) using the commercial screens MemGold1 333 
and MemGold2 (Molecular Dimensions). For the SmMlaA-OmpF samples only, reservoirs 334 
were diluted with 50% glycerol to a final concentration of 10%. Screens were performed at 335 
4°C for KpMlaA-OmpF and 22°C for SmMlaA-OmpF and KpMlaA-OmpK36. Initial hits 336 
(KpMlaA-OmpF: 0.05 M sodium sulfate, 0.05 M lithium sulfate, 0.05 M Tris pH 8.5 and 35 337 
% PEG 400; SmMlaA-OmpF: 0.32 M lithium chloride 0.1M Sodium citrate pH 5.5 and 14% 338 
PEG 400; KpMlaA-OmpK36: 0.04 M magnesium chloride hexahydrate, 0.05 M sodium 339 
chloride, 0.1 M HEPES pH7.5 and 32 % PEG400) were optimized by hanging-drop vapor 340 
diffusion. Crystals were cryoprotected, when needed, by increasing the PEG 400 concentration 341 
to at least 20% and flash-frozen in liquid nitrogen. Diffraction data were collected at 100 K at 342 
the Diamond Light Source (DLS; ED Table 1). Datasets were integrated with XDS35 or DIALS 343 
(for the KpMlaA-OmpK36 dataset)36 and the space groups were determined with Pointless. 344 
Datasets were scaled using Aimless37-38. The KpMlaA-OmpF phase problem was solved by 345 
molecular replacement using Phaser39 with OmpF PDB (2ZFG) as a search model, showing 346 
clear electron density for KpMlaA. Phenix AutoBuild40,41 was run to partially build KpMlaA, 347 
followed by rounds of manual building using Coot42 and refinement with Phenix43. 348 
Subsequently, the SmMlaA-OmpF phase problem was solved via molecular replacement using 349 
KpMlaA-OmpF as a search model. In this case, refinement was carried out with non-350 
crystallographic symmetry (NCS) restraints. OmpK36 (1OSM) and KpMlaA-OmpF 351 
coordinates (manually modified to contain just one KpMlaA monomer) were used for the 352 
KpMlaA-OmpK36 molecular replacement and refinement was carried out in Phenix as 353 
described above. For all models, TLS refinement was included with each protein chain taken 354 
as a separate group. MolProbity44 was used to validate protein geometry and PyMOL45 for the 355 
visualization of the protein structures. The Alignment sequences were made with Aline46 and 356 
the conservation residues were analysed with ConSurf22. The void volumes were calculated 357 
with Hollow47. 358 
 359 
KpMlaA-OmpF cocrystallisation with DMPG. To gain insight into how phospholipids 360 
interact with MlaA we cocrystallised KpMlaA-OmpF with 1,2-Dimyristoyl-sn-glycero-3-361 
phosphoryl-rac-glycerol (DMPG). Crystallization trials were set up as described for KpMlaA-362 
OmpF by adding DMPG (1,2-Dimyristoyl-sn-glycero-3-phosphoryl-rac-glycerol; Anatrace) 363 
from a 12.5 mM stock solution in 10% C8E4 to a final concentration of 2.5 mM. Initial hits 364 
(0.05 M sodium sulfate, 0.05 M lithium sulfate, 0.05 M Tris pH 8.5 and 35 % PEG 400) were 365 
optimized by hanging-drop vapor diffusion. Diffraction data were collected at Diamond Light 366 
Source (ED Table 1) and processed as described above. KpMlaA-OmpF was used as a search 367 
model during molecular replacement. No clear electron density was observed that could 368 
correspond to a DMPG molecule, however density resembling partially ordered 369 
lipopolysaccharide molecules (LPS) was present close to OmpF. These LPS molecules were 370 
built in coot42 adding, sequentially, the individual monomers of the LPS structure followed by 371 
linking the molecules. eLBOW48 was used to calculate the restraints of the different units, and 372 
the model was refined in Phenix43. As before, the model was validated for protein geometry 373 
using MolProbity44. 374 
 375 
Functional assays. Single and double mutations were generated using the Q5® Site-Directed 376 
Mutagenesis (New England BioLabs) following the manufacturer's directions. Primers were 377 
designed using the NEBaseChanger tool (http://nebasechanger.neb.com). Mutations were 378 
introduced into the KpmlaA-pBAD24 vector, and the KpmlaA mutant alleles were PCR 379 
amplified and cloned, under the control of an IPTG inducible promoter, into the low copy 380 
vector pNDM22049 via EcoRI-BamHI. All the mutants were sanger sequenced (Eurofins 381 
Genomics) to confirm that the desired DNA sequence was correctly introduced. A pNDM220 382 
vector carrying the WT kpmlaA gene was also constructed. For the functional assay strains 383 
BW25113 (WT) and JW2343-1 (ΔmlaA754::kan) from the Keio collection50 were used. First, 384 
JW2343-1 was transformed with pCP20, which provides FLP recombinase to remove KanR 385 
and afterwards the ΔmlaA strain was cured of pCP20 at 42 °C51. EcmlaA flanking primers were 386 
designed to check that the deletion of EcmlaA was successful. BW25113 and the cured 387 
JW2343-1 strains were transformed with the desired pNDM220 plasmids and plated onto LB 388 
plus 50 µg/ml of ampicillin. 10-fold serial dilutions of the transformed strains were prepared 389 
(starting culture at OD600 of 0.5) and spotted with a free-floating pin tool (2 mm diameter pins, 390 
V&P scientific) on solid agar plates with 0.5 mM IPTG and 50 µg/ml ampicillin (supplemented 391 
with 120 µg/ml chlorpromazine or 1.2 µg/ml doxycycline as required) in 96-well format using 392 
a Biomek FX robot (Beckman Coulter UK Limited, High Wycombe, UK) incubated at 37°C 393 
and photographed after 18 hours. The results from these in vitro experiments, shown in Figure 394 
3 and Supplementary Figure 7, suggest that drugs targeting the Mla pathway would potentiate 395 
various antibiotics via increasing the permeability of the OM. 396 
 397 
Western blot analysis. 5ml of LB plus ampicillin (50 µg/ml) and IPTG (0.5 mM) were 398 
inoculated with the desired strain and grown to an OD600 of 1, then centrifuged and solubilised 399 
in 250µl of BugBuster protein extraction reagent (Novagen), following incubation for 25 400 
minutes at room temperature with vigorous shaking and finally spun down for 10 minutes at 401 
14000 rpm in a microcentrifuge. The solubilised material was analysed by western blot using 402 
Roche Anti-His6-peroxidase mouse monoclonal antibody (per manufacturer's specifications) 403 
and developed with SuperSignalÒ West Pico Chemiluminescent Substrate (Thermo 404 
Scientific). Chemiluminescent activity was recorded with ChemiDoc Imaging System (Bio 405 
Rad). All the assays have been performed at least in duplicate. 406 
 407 
Competitive fitness experiments in vivo. All animal experiments were approved (license 408 
2239, Kantonales Veterinäramt Basel) and performed per local guidelines (Tierschutz-409 
Verordnung, Basel) and the Swiss animal protection law (Tierschutz-Gesetz). We used the 410 
virulent strain Salmonella enterica serovar Typhimurium SL134452 as parental strain for 411 
constructing a Salmonella ΔmlaA mutant. We tested its in vivo fitness in the mouse typhoid 412 
fever model using competitive infections. Female 8-12 weeks old BALB/c mice were 413 
intravenously infected with a mixture of some 1000 colony-forming units each of SL1344 and 414 
SL1344 ΔmlaA. The exact inoculum dose for each strain was determined by plating. Four days 415 
post infection, mice were sacrificed and spleen homogenates were prepared. Bacterial loads of 416 
SL1344 and SL1344 ΔmlaA were determined and the competitive index was calculated as 417 
(outputΔmlaA / outputSL1344) / (inputΔmlaA / inputSL1344)26. Wild-type fitness would result 418 
in a competitive index of 1, values below 1 indicate compromised in vivo fitness of the ΔmlaA 419 
mutant. Statistical significance was tested using two-tailed t-test on log-transformed 420 
competitive index data (which are normally distributed)26. We estimated sample size by a 421 
sequential statistical design. We first infected 2 mice based on effect sizes and variation 422 
observed in our previous study26. Data analysis suggested that 2 additional mice would be 423 
sufficient to determine statistical significance with sufficient power. To ensure this was the 424 
case, we tested an additional 3 mice (see text). We did neither randomize nor blind the 425 
experiments, as this is irrelevant for competitive infections where a wild-type Salmonella 426 
reference is included in each infected mouse.  427 
 428 
 429 
Molecular dynamics simulations. The OmpF-MlaA assembly was embedded in a lipid 430 
bilayer and solvated with ~48000 water molecules and neutralized with a 150mM 431 
concentration of NaCl salt, bringing the all-atom system size to ~350,000 atoms. Moreover, 432 
the MlaA protein was simulated in absence of a OmpF protein as well, inserted in a 1-433 
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) bilayer. Both the coarse 434 
grained (CG) and the all-atom simulations were carried out using the GROMACS 5.1.2 435 
package53. The CHARMM 36 force field was employed to obtain the parameters for the lipids, 436 
waters, ions and the protein in the atomistic simulations54. For the CG simulations, the 437 
MARTINI 2.0 force field was used for lipids, while the elastic network model with standard 438 
MARTINI constraints was used for the protein and the polarizable water model was used for 439 
the solvent55-57. Concerning the LPS, a Re-LPS (KDO2-lipid A) lipid model, i.e., a minimal 440 
biologically active endotoxin molecule, was used in the CG simulations58, with KDO being 3-441 
deoxy-D-manno-2-octulosonic acid.  The appropriateness of a CG representation for systems 442 
forming water channels in membranes was shown previously59. Although additional lipids such 443 
as Cardiolipin, Phosphatidylglycerol (PG) and Phosphatidylserine (PS) are present in a small 444 
quantity in the inner leaflet of Gram-negative bacterial outer membranes, they were neglected 445 
in the present work for the sake of simplicity. All simulations were carried out at 303 K 446 
temperature to prevent gel phase formation of the lipid bilayer.   447 
For the atomistic simulations, we used a 2 fs timestep with a Verlet integrator. A Nose-Hooever 448 
thermostat60,61 and Parrinello-Rahman barostat62 was employed for maintaining a canonical 449 
ensemble. Standard CHARMM36 settings were used to calculate the forces. Furthermore, 450 
electrostatic forces were calculated with a Particle Mesh Ewald (PME) method using a cutoff 451 
of 1.2 nm63. The London dispersion effects were treated with a switch function with switch at 452 
1 nm and a gradual cutoff at 1.2 nm. For the equilibration, the structure was first minimized 453 
and then short (1 ns) simulations were carried out in which the protein backbone and the lipids 454 
were successively relaxed. A final 100ns of simulation with all restraints removed was used as 455 
the last step of the equilibration process. The atomistic simulations were used to calculate 456 
various parameters for the lipid bilayer (Supplementary Fig. 8), including order parameters for 457 
the lipid tails, the Radial Distribution Function (RDF) for ions with the lipid heads, bilayer 458 
thickness across the box and Area per Lipid (APL) for each leaflet. The Radial Distribution 459 
Function (g(r)) is the distance distribution of the ions from the phosphate head group to the 460 
sodium and the chloride ions. The deuterium (D) order parameters (SCD) calculate the 461 
anisotropy of the C-D bonds in the acyl chains of the lipid. Deuteriums are introduced into the 462 
lipid by substituting the hydrogens bound to the acyl carbons. SCD is a measure of the 463 
simulation average of the angle the C-D vector makes to the lipid bilayer normal and provides 464 
an insight into the flexibility of the lipid tail64. Finally, the stability of the MlaA monomer in 465 
the simulation was tested by calculating its RMSF over the equilibration period, demonstrating 466 
that the structure of MlaA is very stable during the simulation (Supplementary Fig. 8f). 467 
 468 
In the CG simulations, a time step of 20 fs was used for generating the trajectories. A v-rescale 469 
thermostat65 and the Berendsen barostat66 were made use of for maintaining a canonical 470 
ensemble. In addition, a switch function was employed to model dispersion terms. For the 471 
electrostatic terms, a cutoff of 1.2 nm was used and for the dispersion terms the switch occurred 472 
at 0.9 nm to end in a smooth cutoff at 1.2 nm. Similar to atomistic simulations, the CG 473 
simulations were also subjected to first a minimization step and then successively relaxed 474 
simulations (10 ns) in which the constraints on the proteins and the lipids were lowered to a 475 
final step of equilibration simulations for 1 µs without any restraints. 476 
 477 
An orientation map was prepared for the lipids of the bilayer from the simulated trajectories 478 
(Figs. 2c and d and Supplementary Figs. 5a and b). Each disk in this map represents the average 479 
lipid property in each grid space around the protein. The vector drawn at the centre of each 480 
disk shows the average tilt of the lipids with respect to the outer leaflet plane normal. Thus, an 481 
angle of 90 degrees represents a completely horizontal orientation for the lipid and a longer 482 
vector, while an angle of zero degrees implies a vertical orientation and a vector of length zero. 483 
The size of the disk corresponds to the relative density of the lipid in each grid space, i.e. it is 484 
a measure of occupancy of that site. Importantly, the colour of the disk represents the average 485 
depth of the lipid head from the centre of the membrane. 486 
 487 
 488 
References 489 
1. Henderson, J. C. et al. The Power of Asymmetry: Architecture and Assembly of the 490 
Gram-Negative Outer Membrane Lipid Bilayer. Annu. Rev. Microbiol. 70, 255–278 (2016). 491 
2. May, K. L. & Silhavy, T. J. Making a membrane on the other side of the wall. Biochim. 492 
Biophys. Acta (2016). doi:10.1016/j.bbalip.2016.10.004 493 
3. Nikaido, H. Molecular Basis of Bacterial Outer Membrane Permeability Revisited. 494 
Microbiology and Molecular Biology Reviews 67, 593–656 (2003). 495 
4. Malinverni, J. C. & Silhavy, T. J. An ABC transport system that maintains lipid 496 
asymmetry in the gram-negative outer membrane. Proc. Natl. Acad. Sci. U.S.A. 106, 8009–497 
8014 (2009). 498 
5. Ekiert, D. C. et al. Architectures of Lipid Transport Systems for the Bacterial Outer 499 
Membrane. Cell 169, 273–285.e17 (2017). 500 
6. Chong, Z.-S., Woo, W.-F. & Chng, S.-S. Osmoporin OmpC forms a complex with 501 
MlaA to maintain outer membrane lipid asymmetry in Escherichia coli. Mol. Microbiol. 98, 502 
1133–1146 (2015). 503 
7. Snijder HJ, Ubarretxena-Belandia I, Blaauw M, Kalk KH, Verheij HM, Egmond MR, 504 
Dekker N, Dijkstra BW. Structural evidence for dimerization-regulated activation of an 505 
integral membrane phospholipase. Nature. 1999 Oct 14;401(6754):717-21. 506 
8. Russell E. Bishop, Henry S. Gibbons, Tina Guina, M.Stephen Trent, Samuel I. Miller, 507 
Christian R.H. Raetz. Transfer of palmitate from phospholipids to lipid A in outer 508 
membranes of Gram-negative bacteria. EMBO J. 2000 Oct 2; 19(19): 5071–5080. 509 
9. Casali, N. & Riley, L. W. A phylogenomic analysis of the Actinomycetales mce 510 
operons. BMC Genomics 8, 60 (2007). 511 
10. Awai, K., Xu, C., Tamot, B. & Benning, C. A phosphatidic acid-binding protein of the 512 
chloroplast inner envelope membrane involved in lipid trafficking. Proceedings of the National 513 
Academy of Sciences 103, 10817–10822 (2006). 514 
11. Thong, S. et al. Defining key roles for auxiliary proteins in an ABC transporter that 515 
maintains bacterial outer membrane lipid asymmetry. Elife 5, R53 (2016). 516 
12.  Zhao, L. et al. Deletion of the vacJ gene affects the biology and virulence in 517 
Haemophilus parasuis serovar 5. Gene 603, 42–53 (2017). 518 
13. Carpenter, C. D. et al. The Vps/VacJ ABC transporter is required for intercellular 519 
spread of Shigella flexneri. Infect. Immun. 82, 660–669 (2014). 520 
14. Suzuki, T. et al. Identification and characterization of a chromosomal virulence gene, 521 
vacJ, required for intercellular spreading of Shigella flexneri. Mol. Microbiol. 11, 31–41 522 
(1994). 523 
15. Shen, L. et al. PA2800 Plays an Important Role in Both Antibiotic Susceptibility and 524 
Virulence in Pseudomonas aeruginosa. Curr Microbiol 65, 601–609 (2012). 525 
16. Roier, S. et al. A novel mechanism for the biogenesis of outer membrane vesicles in 526 
Gram-negative bacteria. Nat Commun 7, 10515 (2016). 527 
17. Nikaido, H. Restoring permeability barrier function to outer membrane. Chem. Biol. 528 
12, 507–509 (2005). 529 
18. Li, G.-W., Burkhardt, D., Gross, C. & Weissman, J. S. Quantifying absolute protein 530 
synthesis rates reveals principles underlying allocation of cellular resources. Cell 157, 624–531 
635 (2014). 532 
19. Holm, L. & Rosenström, P. Dali server: conservation mapping in 3D. Nucleic Acids 533 
Res. 38, W545–9 (2010). 534 
20.  Arunmanee W. et al. Gram-negative trimeric porins have specific LPS binding sites 535 
that are essential for porin biogenesis. Proc. Natl. Acad. Sci. U.S.A. 113, E5034-43 (2016). 536 
21.  Takeuchi, Y. & Nikaido, H. Persistence of segregated phospholipid domains in 537 
phospholipid-lipopolysaccharide mixed bilayers: studies with spin-labeled phospholipids. 538 
Biochemistry 20, 523–529 (1981).  539 
22. Ashkenazy, H., Erez, E., Martz, E., Pupko, T. & Ben-Tal, N. ConSurf 2010: calculating 540 
evolutionary conservation in sequence and structure of proteins and nucleic acids. Nucleic 541 
Acids Res. 38, W529–33 (2010). 542 
23. Nichols, R. J. et al. Phenotypic landscape of a bacterial cell. Cell 144, 143–156 (2011). 543 
24. Sutterlin, H. A. et al. Disruption of lipid homeostasis in the Gram-negative cell 544 
envelope activates a novel cell death pathway. Proc. Natl. Acad. Sci. U.S.A. 113, E1565–74 545 
(2016). 546 
25.  Filip, C., Fletcher, G., Wulff, J. L. & Earhart, C. F. Solubilization of the cytoplasmic 547 
membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J. Bacteriol. 548 
115, 717–722 (1973). 549 
26. Steeb, B. et al. Parallel exploitation of diverse host nutrients enhances Salmonella 550 
virulence. PLoS Pathog. 9, e1003301 (2013). 551 
27. Dong, C. et al. Wza the translocon for E. coli capsular polysaccharides defines a new 552 
class of membrane protein. Nature 444, 226-229 (2006).  553 
28. Chandran, V., Fronzes, R., Duquerroy, S., Cronin, N., Navaza, J. & Waksman, G. 554 
Structure of the outer membrane complex of a type IV secretion system. Nature 462, 1011-555 
1015 (2009).  556 
29. Hankins, H. M., Baldridge, R. D., Xu, P. & Graham, T. R. Role of flippases, 557 
scramblases and transfer proteins in phosphatidylserine subcellular distribution. Traffic 16, 35–558 
47 (2015). 559 
30. Daleke, D.L. Regulation of transbilayer plasma membrane phospholipid asymmetry. J 560 
Lipid Res. 44, 233–42 (2003) 561 
31. Guzman, L. M., Belin, D., Carson, M. J. & Beckwith, J. Tight regulation, modulation, 562 
and high-level expression by vectors containing the arabinose PBAD promoter. J. Bacteriol. 563 
177, 4121–4130 (1995). 564 
32. Miroux, B. & Walker, J. E. Over-production of proteins in Escherichia coli: mutant 565 
hosts that allow synthesis of some membrane proteins and globular proteins at high levels. 566 
Journal of Molecular Biology 260, 289–298 (1996). 567 
33. Cronan, J. E. A family of arabinose-inducible Escherichia coli expression vectors 568 
having pBR322 copy control. Plasmid 55, 152–157 (2006). 569 
34. Prilipov, A., Phale, P. S., Van Gelder, P., Rosenbusch, J. P. & Koebnik, R. Coupling 570 
site-directed mutagenesis with high-level expression: large scale production of mutant porins 571 
from E. coli. FEMS Microbiol. Lett. 163, 65–72 (1998). 572 
35. Kabsch, W. Integration, scaling, space-group assignment and post-refinement. Acta 573 
Crystallogr. D Biol. Crystallogr. 66, 133–144 (2010). 574 
36. Waterman, D. G. et al. Diffraction-geometry refinement in the DIALS framework. Acta 575 
Crystallogr D Struct Biol 72, 558–575 (2016). 576 
37. Evans, P. R. & Murshudov, G. N. How good are my data and what is the resolution? 577 
Acta Crystallogr. D Biol. Crystallogr. 69, 1204–1214 (2013). 578 
38. Evans, P. Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 579 
62, 72–82 (2006). 580 
39. McCoy, A. J. et al. Phaser crystallographic software. J Appl Crystallogr 40, 658–674 581 
(2007). 582 
40. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for 583 
macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010). 584 
41. Terwilliger, T. C. et al. Iterative model building, structure refinement and density 585 
modification with the PHENIX AutoBuild wizard. Acta Crystallogr. D Biol. Crystallogr. 64, 586 
61–69 (2008).  587 
42. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta 588 
Crystallogr. D Biol. Crystallogr. 60, 2126–2132 (2004). 589 
43. Afonine, P. V. et al. Towards automated crystallographic structure refinement with 590 
phenix.refine. Acta Crystallogr. D Biol. Crystallogr. 68, 352–367 (2012). 591 
44. Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular 592 
crystallography. Acta Crystallogr. D Biol. Crystallogr. 66, 12–21 (2010). 593 
45. The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC. 594 
46. Bond, C. S. & Schüttelkopf, A. W. ALINE: a WYSIWYG protein-sequence alignment 595 
editor for publication-quality alignments. Acta Crystallogr. D Biol. Crystallogr. 65, 510–512 596 
(2009). 597 
47. Ho, B. K. & Gruswitz, F. HOLLOW: generating accurate representations of channel 598 
and interior surfaces in molecular structures. BMC Struct. Biol. 8, 49 (2008). 599 
48. Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder 600 
and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. 601 
Acta Crystallogr. D Biol. Crystallogr. 65, 1074–1080 (2009). 602 
49. Gotfredsen, M. & Gerdes, K. The Escherichia coli relBE genes belong to a new toxin-603 
antitoxin gene family. Mol. Microbiol. 29, 1065–1076 (1998). 604 
50. Baba, T. et al. Construction of Escherichia coli K-12 in-frame, single-gene knockout 605 
mutants: the Keio collection. Mol. Syst. Biol. 2, 2006.0008 (2006). 606 
51. Cherepanov, P. P. & Wackernagel, W. Gene disruption in Escherichia coli: TcR and 607 
KmR cassettes with the option of Flp-catalyzed excision of the antibiotic-resistance 608 
determinant. Gene 158, 9–14 (1995). 609 
52. Hoiseth, S. K. & Stocker, B. A. D. Aromatic-dependent Salmonella typhimurium are 610 
non-virulent and effective as live vaccines. Nature 291, 238-239 (1981). 611 
53. Abraham, M. J. et al. GROMACS: High performance molecular simulations through 612 
multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015). 613 
54. Klauda, J. B. et al. Update of the CHARMM all-atom additive force field for lipids: 614 
validation on six lipid types. J Phys Chem B 114, 7830–7843 (2010). 615 
55. Herzog, F. A., Braun, L., Schoen, I. & Vogel, V. Improved Side Chain Dynamics in 616 
MARTINI Simulations of Protein-Lipid Interfaces. J Chem Theory Comput 12, 2446–2458 617 
(2016). 618 
56. Yesylevskyy, S. O., Schäfer, L. V., Sengupta, D. & Marrink, S. J. Polarizable water 619 
model for the coarse-grained MARTINI force field. PLoS Comput Biol 6, e1000810 (2010). 620 
57. Periole, X., Cavalli, M., Marrink, S.-J. & Ceruso, M. A. Combining an Elastic Network 621 
With a Coarse-Grained Molecular Force Field: Structure, Dynamics, and Intermolecular 622 
Recognition. J Chem Theory Comput 5, 2531–2543 (2009). 623 
58. Hsu, P.-C., Jefferies, D. & Khalid, S. Molecular Dynamics Simulations Predict the 624 
Pathways via Which Pristine Fullerenes Penetrate Bacterial Membranes. J Phys Chem B 120, 625 
11170–11179 (2016). 626 
59. Bennett, W. F. D. & Tieleman, D. P. Water Defect and Pore Formation in Atomistic 627 
and Coarse-grained Lipid Membranes: Pushing the Limits of Coarse Graining 628 
J. Chem. Theory Comput. 7, 2981-2988 (2011). 629 
60. Hoover, W. G. Canonical dynamics: Equilibrium phase-space distributions. Phys. 630 
Rev. A 31, 1695–1697 (1985). 631 
61. Andersen, H. C. & C., H. Molecular dynamics simulations at constant pressure and/or 632 
temperature. J. Chem. Phys. 72, 2384–2393 (1980). 633 
62. Parrinello, M. & Rahman, A. Polymorphic transitions in single crystals: A new 634 
molecular dynamics method. J. Appl. Phys. 52, 7182–7190 (1981). 635 
63. Darden, T., York, D. & Pedersen, L. Particle mesh Ewald: An N⋅ log(N) method for 636 
Ewald sums in large systems. J. Chem. Phys. 98, 10089–10092 (1993). 637 
64. Vermeer, L.S., de Groot, B.L., Réat, V., Milon, A. & Czaplicki, J. Acyl chain order 638 
parameter profiles in phospholipid bilayers: computation from molecular dynamics 639 
simulations and comparison with 2H NMR experiments. Eur Biophys J. 36, 919-931 (2007). 640 
65. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity 641 
rescaling. J. Chem. Phys. 126, 14101–14107 (2007). 642 
66. Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A. & Haak, J. R. 643 
Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684–3690 (1984). 644 
67. Jo, S., Vargyas, M., Vasko-Szedlar, J., Roux, B. & Im, W. PBEQ-Solver for online 645 
visualization of electrostatic potential of biomolecules. Nucleic Acids Res. 36, W270–5 (2008). 646 
68. Smart, O.S., Neduvelil, J.G., Wang, X., Wallace, B., Sansom, M.S. HOLE: a program 647 
for the analysis of the pore dimensions of ion channel structural models. J. Mol. Graph.  14, 648 
354–360 (1996). 649 
69. Humphrey, W. F., Dalke, A. & Schulten, K. VMD -- Visual Molecular Dynamics, J. 650 
Mol. Graph. 14, 33-38 (1996). 651 
 652 
Data availability 653 
Coordinates and structure factors have been deposited in the Protein Data Bank with accession 654 
codes 5NUO for KpMlaA-OmpF, 5NUP for KpMlaA-OmpK36, 5NUQ for SmMlaA-OmpF 655 
and 5NUR for KpMlaA-OmpF-LPS.  656 
 657 
Correspondence and requests for materials should be addressed to Bert van den Berg (bert.van-658 
den-berg@ncl.ac.uk). 659 
Acknowledgements 660 
We would like to thank the staff at beam lines I24, I04 and I04-1 of the Diamond Light Source 661 
UK for beam time (proposal mx13587) and assistance with data collection. The research of 662 
SSK, UK, DB and BvdB has received support from the Innovative Medicines Initiatives Joint 663 
Undertaking under Grant Agreement No. 115525, resources which are composed of financial 664 
contributions from the European Union’s seventh framework programme (FP7/2007-2013) and 665 
European Federation of Pharmaceutical Industries and Associations companies in-kind 666 
contribution. 667 
 668 
Author contributions 669 
B.v.d.B and J.A-R. purified MlaA proteins, crystallised MlaA-OmpF complexes, and 670 
determined crystal structures. J.A-R. constructed MlaA variant proteins and conducted in vitro 671 
functional assays. S.S.K carried out and analysed MD simulations. U.K. supervised the 672 
computational studies. A.B. collected X-ray diffraction data and maintained the Newcastle 673 
Structural Biology Laboratory. B.C. carried out competitive fitness experiments, supervised by 674 
D.B. B.v.d.B and J.A-R designed experiments and B.v.d.B wrote the paper, with input from all 675 
co-authors. 676 
 677 
Competing interests 678 
The authors declare no competing financial interests.  679 
 680 
 681 
 682 
 683 
 684 
 685 
 686 
 687 
 688 
 689 
 690 
Figures 691 
 692 
Figure 1 | MlaA is a monomeric a-helical OM protein with a central channel. a, b, Cartoon 693 
representations from the OM plane (a) and from the outside of the cell (b) for KpMlaA-OmpF 694 
(left panel) and SmMlaA-OmpF (right panel). One monomer each for MlaA and OmpF is 695 
shown in rainbow colouring (N-terminus; blue). The hydrophobic core of the OM is shown in 696 
grey. c, Cartoon superposition of KpMlaA (rainbow) and SmMlaA (light green) with structural 697 
elements labelled and the channel location indicated with an asterisk. The right panel shows a 698 
side view of KpMlaA as in (a) with transparent surface. d, Surface views in rainbow colouring 699 
from the outside of the cell (left panel) and from the periplasmic side (right panel). e-g, 700 
Electrostatic surfaces (-15 kT/e to 15kT/e) of the KpMlaA-OmpF dimer generated via PBEQ 701 
solver67 viewed from the outside of the cell (e), the plane of the OM (f) and the periplasmic 702 
space (g). All crystal structure figures were generated with Pymol45. 703 
 704 
 705 
 706 
 707 
 708 
 709 
Figure 2 | MlaA binds OM phospholipids. a, Profile of the central MlaA channel generated 710 
with HOLE68, including variations along the atomistic MD trajectories. Representative 711 
positions and orientations of the phospholipid at the start (grey) and end (yellow) of the 712 
simulations are indicated.  b, MD snapshot from the OM plane after 200 ns atomistic 713 
simulation, showing the POPE molecule at the start and end of the simulation (oxygens, red; 714 
nitrogens, blue). MlaA is shown as a cartoon and coloured light blue. Phosphate head groups 715 
are shown as olive and green balls for the outer and inner leaflets respectively, water molecules 716 
as small blue spheres. The centre of the channel is indicated by the orange line. Residue Asp152 717 
interacting with the POPE head group is labelled. c, d Interaction diagrams obtained from the 718 
second half of 2 µs coarse-grained MD simulations for Re LPS (c) and POPE (d). The Z-719 
coordinate of the phospholipid is represented by a coloured sphere, with the sphere diameter 720 
proportional to the occupancy at that site. The OmpF trimer is indicated by the central green 721 
circle and the individual MlaA monomers by black circles. The length and direction of the 722 
arrows represent the tilt angles of the phospholipid acyl chains (see Methods). All figures and 723 
movies from simulations were generated with VMD69. 724 
 725 
 726 
Figure 3 | Functional analyses of MlaA. a, cartoon views from the extracellular side (left 727 
panel) and from the OM plane showing the locations of mutated residues, coloured by ConSurf 728 
conservation score. b, In vitro complementation of growth defects on LB agar plates in the 729 
presence of doxycycline. Cells were spotted in serial dilutions. Growth of the WT strain is 730 
compared to strains with a deletion of EcmlaA and complemented with an "empty" low copy 731 
number vector (EcmlaAD), or with the same vector harbouring wild type His-tagged KpmlaA 732 
(+) or different KpmlaA mutant alleles. The bottom panels show His-tag western blots of total 733 
membranes, indicating all variant proteins are expressed in the OM. Panels are representative 734 
of 4 experiments for the growth assays and 2 experiments for the western blots. c, In vitro 735 
complementation of the Y138C/W170C mutant in the absence and presence of reducing agent. 736 
Panel is representative of 3 experiments. d, Competitive Index (CI) of the DmlaA strain in a 737 
Salmonella typhoid fever mouse model. Each circle represents data from one mouse from a 738 
total of two independent experiments (n = 5; **,P < 0.01). The dashed line corresponds to wild-739 
type fitness. Statistical significance was tested using two-tailed t-test on log-transformed 740 
competitive index data. 741 
 742 
 743 
 744 
 745 
  746 
Figure 4 | MlaA is an outer leaflet phospholipid translocation channel. a, Schematic 747 
overview of the MlaA transport mechanism, viewed from the OM plane. Access of inner leaflet 748 
phospholipids (PL) to the channel is prevented by the MlaA walls surrounding the central 749 
channel. By contrast, outer leaflet PL can access the channel and are removed from the OM 750 
via transfer to MlaC in the periplasmic space. b, Schematic views from the outside of the cell 751 
showing the relative locations of H1 (blue), H6 (orange) and the pore loop (yellow) using the 752 
same colour code as in a. State 1 represents the crystal structures, in which MlaA has a small, 753 
hydrophilic pore. After rearrangements of the pore loop (arrow), helix H6 or both, MlaA has 754 
an enlarged pore that is amphipathic (state 2). State 3 shows the putative disruption of H1 in 755 
the N26-F27D MlaA* variant, allowing lateral access of inner leaflet phospholipids to the 756 
central channel (arrow). The polar part of the amphipathic pore is coloured red, the 757 
hydrophobic part grey. For clarity, the translocating phospholipid molecule is not shown. 758 
